OxTalks is Changing
OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
The efficacy and safety of pramipexole augmentation in treatment resistant depression: Results of the PAX-D trial.
There has been interest in the use of dopaminergic agonists in patients with treatment resistant depression (TRD), although they have only been assessed in small-scale, short-term studies. We conducted a substantial RCT examining the effect and safety/tolerability of the dopamine agonist pramipexole in patients with TRD, the PAX-D trial. In this talk I will present the efficacy and safety results from the trial.
This seminar is hosted in person and online, to join online, please use the Zoom details below:
zoom.us/j/93598736019?pwd=tHJ65nmXIrmYTUhi7YRbbdlnyi5Ie6.1
Meeting ID: 935 9873 6019
Passcode: 897963
Date:
4 March 2025, 9:30
Venue:
Department of Psychiatry, Headington OX3 7JX
Venue Details:
Seminar Room
Speaker:
Professor Michael Browning (Department of Psychiatry, University of Oxford)
Organising department:
Department of Psychiatry
Organiser:
Rania Elgarf (Department of Psychiatry, University of Oxford)
Organiser contact email address:
rania.elgarf@psych.ox.ac.uk
Host:
Professor Phil Cowen (Professor of Psychopharmacology, University of Oxford )
Part of:
Psychiatry Seminar Series
Booking required?:
Not required
Audience:
Public
Editor:
Rania Elgarf
